Main Degree:Medicine and Surgery, Universitiy of Genoa, 1979
Postgraduated degree Pediatrics,University of Genoa 1984
Postgraduated degree Pediatric Neurology and Psychiatry ,University of Genoa, 1987
RESEARCH INTERESTS
Genetic diseases,
Metabolic diseases
283
Scopus Publications
13480
Scholar Citations
63
Scholar h-index
198
Scholar i10-index
Scopus Publications
Mitochondrial energetic failure underlies FLVCR1-related sensory neuropathy Francesca Bertino, Diletta Isabella Zanin Venturini, Eleonora Grasso, Joanna Kopecka, Chiara Salio, Barbara Gnutti, Ram Manohar Basnet, Stefania Bellini, Luca Mignani, Boxun Zhao, Felix Kleefeld, Andreas Hentschel, Francesca Magnani, Veronica Fiorito, Raluca Elena Abalai, Livia Metani, Anna Lucia Allocco, Sara Petrillo, Francesco De Giorgio, Giorgia Ammirata, Ettore Salsano, Davide Pareyson, Maja di Rocco, Angela Abicht, Emily McCourt, Rita Horvath, Heike Kölbel, Austin Larson, Andreas Roos, Timothy W. Yu, Dario Finazzi, Chiara Riganti, Emanuela Tolosano, Deborah Chiabrando Communications Biology, 2026 Genetic pain loss disorders represent a heterogeneous group of rare diseases mainly characterized by defective nociception. Understanding the underlying molecular mechanism is fundamental to improve the treatment of patients affected by these rare disorders. Feline Leukemia Virus Subgroup C Receptor 1 (FLVCR1) is one of the genes previously associated with sensory neuropathy that requires further investigation. Here, we report on two additional patients with novel disease-causing variants in FLVCR1 and introduce a zebrafish model of the disease. The analyses of patient-derived fibroblasts show that distinct FLVCR1 variants compromised all the known functions associated with FLVCR1, thus affecting choline levels, heme biosynthesis and mitochondrial Ca2+ handling. Furthermore, we provide evidence that the alteration of these processes impairs the TCA cycle and OXPHOS, and induces lipid peroxidation. Our data points to the alterations of energetic metabolism as a potential driving pathomechanism in FLVCR1-associated sensory neuropathy. Functional studies of pathogenetic FLVCR1 variants associated with sensory neuropathy reveal that impaired choline uptake, heme biosynthesis, and ER–mitochondria Ca²⁺ transfer result in mitochondrial energetic failure.
Hearing loss predictive model in fibrodysplasia ossificans progressiva from a national referral center: developing an hearing loss predictive model Tommaso Cacco, Riccardo Papa, Luca Carmisciano, Carola Bruzzo, Lucia Semino, Alberto Tonelli, Caterina Matucci-Cerinic, Maja Di Rocco, Renata Bocciardi, Marco Gattorno, Roberto D’Agostino Jbmr Plus, 2025 Fibrodysplasia ossificans progressiva (FOP) is the most dramatic form of progressive heterotopic ossification of soft tissues. Hearing impairment in FOP patient is a common feature, reported by about 50% of affected patients. However, wide case series considering audiologic features are lacking. We report the audiologic history of a group of FOP patients in order to define the hearing loss characteristics, genotype association, and possible rehabilitative options. We report audiometric history of 16 FOP patients referred to our Institute from 2014 onwards without ear malformations or other known reason for audiologic impairment. Major involvement of high frequencies in our FOP cohort suggests that the position of the high-frequency receptors within the cochlea, near the oval window, makes them more exposed to damage than the low-frequency receptors located deeper in the cochlea. Furthermore, the reported gender difference may be secondary to a hormonal effect, as known in patients with otosclerosis. Finally, regarding the genotype, we noted that only the non-classic patient carrying the ACVR1 c.619C>G; p.Q207E mutation, presented a mixed hypoacusia with a sensorineural component prevailing on acute frequencies, currently not deserving hearing aids. This evidence suggests a possible novel genotype association to be confirmed in larger cohort. The present analysis shows that a longer disease history is associated with a statistically significant worse hearing loss, mainly involving the high frequencies. The advent of new therapeutic options highlights the relevance of having comparative follow-up data in order to evaluate the effectiveness of these new therapies against all the various clinical manifestations of FOP.
The European reference network for metabolic diseases (MetabERN) clinical pathway recommendations for Pompe disease (acid maltase deficiency, glycogen storage disease type II) Giancarlo Parenti, Simona Fecarotta, Marianna Alagia, Federica Attaianese, Alessandra Verde, Antonietta Tarallo, Vincenza Gragnaniello, Athanasia Ziagaki, Maria Jose’ Guimaraes, Patricio Aguiar, Andreas Hahn, Olga Azevedo, Maria Alice Donati, Beata Kiec-Wilk, Maurizio Scarpa, Nadine A. M. E. van der Beek, Mireja Del Toro Riera, Dominique P. Germain, Hidde Huidekoper, Johanna M. P. van den Hout, Ans T. van der Ploeg, , Ivo Baric, Spyros Batzios, Nadia Belmatoug, Andrea Bordugo, Annet M. Bosch, Anais Brassier, Alberto Burlina, David Cassiman, Brigitte Chabrol, Efstathia Chronopoulou, Maria Luz Couce-Pico, Niklas Darin, Anibh M. Das, Francois G. Debray, Patrick Deegan, Luisa M. de Abreu Freire Diogo Matos, Javier De Las Heras Montero, Maja Di Rocco, Dries Dobbelaere, Francois Eyskens, Ana Ferreira, Ana M. Gaspar, Serena Gasperini, Antonio González-Meneses López, Salvatore Grosso, Nathalie Guffon-Fouilhoux, Julia Hennermann, Tarekegn G. Hiwot, Simon Jones, Sandra Kingma, Veroniki Komninaka, Elena Martín-Hernández, Esmeralda Martins, Diana Miclea, György Pfliegler, Esmeralda Rodrigues, Dariusz Rokicki, Dominique Roland, Frank Rutsch, Alessandro Salviati, Ivailo Tournev, Kurt Ullrich, Peter M. van Hasselt, Suresh Vijay, Natalie Weinhold, Peter Witters, Jiri Zeman Orphanet Journal of Rare Diseases, 2024 Clinical pathway recommendations (CPR) are based on existing guidelines and deliver a short overview on how to deal with a specific diagnosis, resulting therapy and follow-up. In this paper we propose a methodology for developing CPRs for Pompe disease, a metabolic myopathy caused by deficiency of lysosomal acid alpha-glucosidase. The CPR document was developed within the activities of the MetabERN, a non-profit European Reference Network for Metabolic Diseases established by the European Union. A working group was selected among members of the MetabERN lysosomal storage disease subnetwork, with specific expertise in the care of Pompe disease, and patient support group representatives. The working strategy was based on a systematic literature search to develop a database, followed by quality assessment of the studies selected from the literature, and by the development of the CPR document according to a matrix provided by MetabERN. Quality assessment of the literature and collection of citations was conducted according to the AGREE II criteria and Grading of Recommendations, Assessment, Development and Evaluation methodology. General aspects were addressed in the document, including pathophysiology, genetics, frequency, classification, manifestations and clinical approach, laboratory diagnosis and multidisciplinary evaluation, therapy and supportive measures, follow-up, monitoring, and pregnancy. The CPR document that was developed was intended to be a concise and easy-to-use tool for standardization of care for patients among the healthcare providers that are members of the network or are involved in the care for Pompe disease patients.
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: A post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial Richard Keen, Kathryn M Dahir, Jennifer McGinniss, Robert J Sanchez, Scott Mellis, Aris N Economides, Maja Di Rocco, Philippe Orcel, Christian Roux, Jacek Tabarkiewicz, Javier Bachiller-Corral, Angela M Cheung, Mona Al Mukaddam, Kusha Mohammadi, Jing Gu, Dushyanth Srinivasan, Dinko Gonzalez Trotter, E Marelise W Eekhoff, Frederick S Kaplan, Robert J Pignolo Journal of Bone and Mineral Research, 2024 Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare disorder, characterized by progressive heterotopic ossification (HO) and painful soft-tissue inflammatory flare-ups. This was a post hoc analysis from a phase 2 (NCT03188666) trial in which adults with FOP received intravenous anti-activin A antibody garetosmab 10 mg/kg or placebo every 4 wk over 28 wk (Period 1), followed by a 28-wk open-label treatment and extension (Periods 2 and 3). Here we describe flare-ups, their relationship to new HO lesions, and the impact of garetosmab on flare-ups. Volume of new HO lesions was measured by CT. Patient-reported flare-ups were defined by any 2 of the following: new onset of pain, swelling, joint stiffness, decrease in movement, or perceived presence of HO. Flare-ups were experienced by 71% (17/24) of placebo-treated patients, 59% (10/17) of whom developed a new HO lesion irrespective of flare-up location; 24% of flare-ups location-matched new HO lesions. Twenty-nine new HO lesions occurred in the placebo cohort by week 28, of which 12 (41%) occurred in the same location as new or ongoing flare-ups. A higher volume of newly formed heterotopic bone (week 28) occurred in placebo-treated patients who had experienced a prior flare-up vs those without (median [Q1:Q3] of 16.6 [12.0:31.1] vs 3.2 cm3). Garetosmab was previously shown to decrease patient-reported flare-up frequency in Period 1; here, garetosmab reduced the median (Q1:Q3) duration of patient-reported flares (15.0 [6.0:82.0] vs 48.0 [15.0:1.00] d) and the severity of flare-ups vs placebo. Frequency of corticosteroid use was numerically reduced in those treated with garetosmab (40.0%) vs placebo (58.3%). In this analysis, 71% of placebo-treated adults with FOP experienced flare-ups over 28 wk, which were associated with an increased volume of newly formed heterotopic bone. Garetosmab reduced the severity and duration of flare-ups, with effects sustained during the entire trial.
Dysregulation of FLVCR1a-dependent mitochondrial calcium handling in neural progenitors causes congenital hydrocephalus Francesca Bertino, Dibyanti Mukherjee, Massimo Bonora, Christoph Bagowski, Jeannette Nardelli, Livia Metani, Diletta Isabella Zanin Venturini, Diego Chianese, Nicolas Santander, Iris Chiara Salaroglio, Andreas Hentschel, Elisa Quarta, Tullio Genova, Arpana Arjun McKinney, Anna Lucia Allocco, Veronica Fiorito, Sara Petrillo, Giorgia Ammirata, Francesco De Giorgio, Evan Dennis, Garrett Allington, Felicitas Maier, Moneef Shoukier, Karl-Philipp Gloning, Luca Munaron, Federico Mussano, Ettore Salsano, Davide Pareyson, Maja di Rocco, Fiorella Altruda, Georgia Panagiotakos, Kristopher T. Kahle, Pierre Gressens, Chiara Riganti, Paolo P. Pinton, Andreas Roos, Thomas Arnold, Emanuela Tolosano, Deborah Chiabrando Cell Reports Medicine, 2024 Congenital hydrocephalus (CH), occurring in approximately 1/1,000 live births, represents an important clinical challenge due to the limited knowledge of underlying molecular mechanisms. The discovery of novel CH genes is thus essential to shed light on the intricate processes responsible for ventricular dilatation in CH. Here, we identify FLVCR1 (feline leukemia virus subgroup C receptor 1) as a gene responsible for a severe form of CH in humans and mice. Mechanistically, our data reveal that the full-length isoform encoded by the FLVCR1 gene, FLVCR1a, interacts with the IP3R3-VDAC complex located on mitochondria-associated membranes (MAMs) that controls mitochondrial calcium handling. Loss of Flvcr1a in mouse neural progenitor cells (NPCs) affects mitochondrial calcium levels and energy metabolism, leading to defective cortical neurogenesis and brain ventricle enlargement. These data point to defective NPCs calcium handling and metabolic activity as one of the pathogenetic mechanisms driving CH.
Multicentric Carpo-Tarsal Osteolysis Syndrome (MCTO) and “Function Profile”: a rehabilitative approach Anna Bruna Ronchetti, Marina Usai, Valentina Savino, Marco Scaglione, Chiara Maria Tacchino, Marta Bertamino, Paolo Moretti, Maja Di Rocco Orphanet Journal of Rare Diseases, 2023 Background Multicentric Carpo-Tarsal Osteolysis Syndrome (MCTO) is an autosomal dominant disease with increased bone reabsorption in the carpus and tarsus and the elbows, knees and spine. The disease is extremely heterogeneous and secondary and tertiary injuries vary widely and can lead to progressive disability and severe functional limitations. In addition to the available and upcoming drug therapies, physical medicine and rehabilitation are important treatment options. Currently, the indication and plan are overlooked, nonspecific and reported only for one patient. Methods We describe a case series of MCTO patients diagnosed and followed by a centre to identify functional deficit as a potential clinical marker of disease progression for future etiological therapies. In addition, we define a symptomatic treatment approach and specific clinical management, including a patient-centred rehabilitation approach. Functional assessments are performed independently by a multidisciplinary group to establish the functional abilities of patients and the relationship between residual motor skills and their degree of autonomy and participation. We suggest a way to identify a rehabilitation plan based on a specific disease using the International Classification of Functioning, Disability and Health Children and Youth (ICF-CY). Results To define a reliable and reproducible “Function Profile”, through age and over time, we used to value the disease status according to the ICF-CY domains. It could be used to determine the complexity of the illness, its overall impact on the complexity of the person and the burden on the caregiver, and an eventual short- and long-term rehabilitation plan for MCTO and other ultra-rare diseases. Conclusion Based on the MCTO experience, we suggest a way to determine a rehabilitation plan based on a specific disease and patient needs, keeping in mind that often the final point is not recovering the full function but improving or maintaining the starting point. In all cases, each patient at the time of diagnosis requires a functional assessment that must be repeated over time to adjust the course of rehabilitation. The evaluations revealed the importance of early rehabilitation management in enhancing independence, participation and control of stress deconditioning, shrinking of muscle tendons and loss of movement to immobility.
Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency Maja Di Rocco, Carlo Dionisi Vici, Alberto Burlina, Francesco Venturelli, Agata Fiumara, Simona Fecarotta, Maria Alice Donati, Marco Spada, Daniela Concolino, Andrea Pession Orphanet Journal of Rare Diseases, 2023 Background GD and ASMD are lysosomal storage disorders that enter into differential diagnosis due to the possible overlap in their clinical manifestations. The availability of safe and effective enzymatic therapies has recently led many investigators to develop and validate new screening tools, such as algorithms, for the diagnosis of LSDs where the lack of disease awareness or failure to implement newborn screening results in a delayed diagnosis. Results the proposed algorithm allows for the clinical and biochemical differentiation between GD and ASMD. It is based on enzyme activity assessed on dried blood spots by multiplexed tandem mass spectrometry (MS/MS) coupled to specific biomarkers as second-tier analysis. Conclusions we believe that this method will provide a simple, convenient and sensitive tool for the screening of a selected population that can be used by pediatricians and other specialists (such as pediatric hematologists and pediatric hepatologists) often engaged in diagnosing these disorders.
GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia Andrea Pession, Maja Di Rocco, Francesco Venturelli, Barbara Tappino, William Morello, Nicola Santoro, Paola Giordano, Beatrice Filippini, Simona Rinieri, Giovanna Russo, Katia Girardi, Antonio Ruggiero, Eulalia Galea, Roberto Antonucci, Nicola Tovaglieri, Fulvio Porta, Immacolata Tartaglione, Fiorina Giona, Franca Fagioli, Alberto Burlina, Rosamaria Mura, Bambina Russo, Assunta Tornesello, Giuseppe Menna, Delia Russo, Maurizio Caniglia, Sergio Schettini, Daniela Onofrillo, Saverio Ladogana, Adele Civino, and Orphanet Journal of Rare Diseases, 2023 Background Gaucher disease (GD) diagnosis can be delayed due to non-specific symptoms and lack of awareness, leading to unnecessary procedures and irreversible complications. GAU-PED study aims to assess GD prevalence in a high-risk pediatric population and the presence, if any, of novel clinical or biochemical markers associated with GD. Materials and methods DBS samples were collected and tested for β-glucocerebrosidase enzyme activity for 154 patients selected through the algorithm proposed by Di Rocco et al. Patients showing β-glucocerebrosidase activity below normal values were recalled to confirm the enzyme deficiency with the gold standard essay on cellular homogenate. Patients tested positive at the gold standard analysis were evaluated through GBA1 gene sequencing. Results 14 out of 154 patients were diagnosed with GD, with a prevalence of 9.09% (5.06–14.78%, CI 95%). Hepatomegaly, thrombocytopenia, anemia, growth delay/deceleration, elevated serum ferritin, elevated Lyso-Gb1 and chitotriosidase were significantly associated with GD. Conclusions GD prevalence in a pediatric population at high-risk appeared to be higher compared to high-risk adults. Lyso-Gb1 was associated with GD diagnosis. The algorithm proposed by Di Rocco et al. can potentially improve the diagnostic accuracy of pediatric GD, allowing the prompt start of therapy, aiming to reduce irreversible complications.
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial Maja Di Rocco, Eduardo Forleo-Neto, Robert J. Pignolo, Richard Keen, Philippe Orcel, Thomas Funck-Brentano, Christian Roux, Sami Kolta, Annalisa Madeo, Judith S. Bubbear, Jacek Tabarkiewicz, Małgorzata Szczepanek, Javier Bachiller-Corral, Angela M. Cheung, Kathryn M. Dahir, Esmée Botman, Pieter G. Raijmakers, Mona Al Mukaddam, Lianne Tile, Cynthia Portal-Celhay, Neena Sarkar, Peijie Hou, Bret J. Musser, Anita Boyapati, Kusha Mohammadi, Scott J. Mellis, Andrew J. Rankin, Aris N. Economides, Dinko Gonzalez Trotter, Gary A. Herman, Sarah J. O’Meara, Richard DelGizzi, David M. Weinreich, George D. Yancopoulos, E. Marelise W. Eekhoff, Frederick S. Kaplan Nature Medicine, 2023 Fibrodysplasia ossificans progressiva (FOP) is a rare disease characterized by heterotopic ossification (HO) in connective tissues and painful flare-ups. In the phase 2 LUMINA-1 trial, adult patients with FOP were randomized to garetosmab, an activin A-blocking antibody (n = 20) or placebo (n = 24) in period 1 (28 weeks), followed by an open-label period 2 (28 weeks; n = 43). The primary end points were safety and for period 1, the activity and size of HO lesions. All patients experienced at least one treatment-emergent adverse event during period 1, notably epistaxis, madarosis and skin abscesses. Five deaths (5 of 44; 11.4%) occurred in the open-label period and, while considered unlikely to be related, causality cannot be ruled out. The primary efficacy end point in period 1 (total lesion activity by PET–CT) was not met (P = 0.0741). As the development of new HO lesions was suppressed in period 1, the primary efficacy end point in period 2 was prospectively changed to the number of new HO lesions versus period 1. No placebo patients crossing over to garetosmab developed new HO lesions (0% in period 2 versus 40.9% in period 1; P = 0.0027). Further investigation of garetosmab in FOP is ongoing. ClinicalTrials.gov identifier NCT03188666.
Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy—a Delphi consensus Maurizio Scarpa, Antonio Barbato, Annalisa Bisconti, Alberto Burlina, Daniela Concolino, Federica Deodato, Maja Di Rocco, Carlo Dionisi-Vici, Maria Alice Donati, Simona Fecarotta, Agata Fiumara, Carlotta Galeone, Fiorina Giona, Gaetano Giuffrida, Raffaele Manna, Paolo Mariani, Andrea Pession, Annalisa Scopinaro, Marco Spada, Federico Spandonaro, Gianluca Trifirò, Francesca Carubbi, Maria Domenica Cappellini Internal and Emergency Medicine, 2023
Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles Elisabeth M.W. Eekhoff, Ruben D. de Ruiter, Bernard J. Smilde, Ton Schoenmaker, Teun J. de Vries, Coen Netelenbos, Edward C. Hsiao, Christiaan Scott, Nobuhiko Haga, Zvi Grunwald, Carmen L. De Cunto, Maja di Rocco, Patricia L. R. Delai, Robert J. Diecidue, Vrisha Madhuri, Tae-Joon Cho, Rolf Morhart, Clive S. Friedman, Michael Zasloff, Gerard Pals, Jae-Hyuck Shim, Guangping Gao, Frederick Kaplan, Robert J. Pignolo, Dimitra Micha Human Gene Therapy, 2022
Expanding the clinical and neuroimaging features of post-varicella arteriopathy of childhood Marta Bertamino, , Sara Signa, Marco Veneruso, Giulia Prato, Roberta Caorsi, Giuseppe Losurdo, Federica Teutonico, Silvia Esposito, Francesca Formica, Nicola Tovaglieri, Maria A. Nagel, Giulia Amico, Alice Zanetti, Domenico Tortora, Andrea Rossi, Paolo Moretti, Marco Gattorno, Angelo Ravelli, Mariasavina Severino Journal of Neurology, 2021
Erratum: Biallelic variants in HPDL cause pure and complicated hereditary spastic paraplegia (Brain (2021) 144:5 (1422-1434) DOI: 10.1093/brain/awab041) Manuela Wiessner, Reza Maroofian, Meng-Yuan Ni, Andrea Pedroni, Juliane S Müller, Rolf Stucka, Christian Beetz, Stephanie Efthymiou, Filippo M Santorelli, Ahmed A Alfares, Changlian Zhu, Anna Uhrova Meszarosova, Elham Alehabib, Somayeh Bakhtiari, Andreas R Janecke, Maria Gabriela Otero, Jin Yun Helen Chen, James T Peterson, Tim M Strom, Peter De Jonghe, Tine Deconinck, Willem De Ridder, Jonathan De Winter, Rossella Pasquariello, Ivana Ricca, Majid Alfadhel, Bart P van de Warrenburg, Ruben Portier, Carsten Bergmann, Saghar Ghasemi Firouzabadi, Sheng Chih Jin, Kaya Bilguvar, Sherifa Hamed, Mohammed Abdelhameed, Nourelhoda A Haridy, Shazia Maqbool, Fatima Rahman, Najwa Anwar, Jenny Carmichael, Alistair T Pagnamenta, Nick W Wood, Frederic Tran Mau-Them, Tobias Haack, Maja Di Rocco, Isabella Ceccherini, Michele Iacomino, Federico Zara, Vincenzo Salpietro, Marcello Scala, Marta Rusmini, Yiran Xu, Yinghong Wang, Yasuhiro Suzuki, Kishin Koh, Haitian Nan, Hiroyuki Ishiura, Shoji Tsuji, Laëtitia Lambert, Emmanuelle Schmitt, Elodie Lacaze, Hanna Küpper, David Dredge, Cara Skraban, Amy Goldstein, Mary J H Willis, Katheryn Grand, John M Graham, Richard A Lewis, Francisca Millan, Özgür Duman, Nihal Olgac Dundar, Gökhan Uyanik, Ludger Schöls, Peter Nürnberg, Gudrun Nürnberg, Andrea Català-Bordes, Pavel Seeman, Martin Kuchar, Hossein Darvish, Adriana Rebelo, Filipa Bouçanova, Jean-Jacques Medard, Roman Chrast, Michaela Auer-Grumbach, Fowzan S Alkuraya, Hanan Shamseldin, Saeed Al Tala, Jamileh Rezazadeh Varaghchi, Maryam Najafi, Selina Deschner, Dieter Gläser, Wolfgang Hüttel, Michael C Kruer, Erik-Jan Kamsteeg, Yoshihisa Takiyama, Stephan Züchner, Jonathan Baets, Matthis Synofzik, Rebecca Schüle, Rita Horvath, Henry Houlden, Luca Bartesaghi, Hwei-Jen Lee, Konstantinos Ampatzis, Tyler Mark Pierson, Jan Senderek, and Brain, 2021
Biallelic variants in HPDL cause pure and complicated hereditary spastic paraplegia Manuela Wiessner, Reza Maroofian, Meng-Yuan Ni, Andrea Pedroni, Juliane S Müller, Rolf Stucka, Christian Beetz, Stephanie Efthymiou, Filippo M Santorelli, Ahmed A Alfares, Changlian Zhu, Anna Uhrova Meszarosova, Elham Alehabib, Somayeh Bakhtiari, Andreas R Janecke, Maria Gabriela Otero, Jin Yun Helen Chen, James T Peterson, Tim M Strom, Peter De Jonghe, Tine Deconinck, Willem De Ridder, Jonathan De Winter, Rossella Pasquariello, Ivana Ricca, Majid Alfadhel, Bart P van de Warrenburg, Ruben Portier, Carsten Bergmann, Saghar Ghasemi Firouzabadi, Sheng Chih Jin, Kaya Bilguvar, Sherifa Hamed, Mohammed Abdelhameed, Nourelhoda A Haridy, Shazia Maqbool, Fatima Rahman, Najwa Anwar, Jenny Carmichael, Alistair Pagnamenta, Nick W Wood, Frederic Tran Mau-Them, Tobias Haack, Maja Di Rocco, Isabella Ceccherini, Michele Iacomino, Federico Zara, Vincenzo Salpietro, Marcello Scala, Marta Rusmini, Yiran Xu, Yinghong Wang, Yasuhiro Suzuki, Kishin Koh, Haitian Nan, Hiroyuki Ishiura, Shoji Tsuji, Laëtitia Lambert, Emmanuelle Schmitt, Elodie Lacaze, Hanna Küpper, David Dredge, Cara Skraban, Amy Goldstein, Mary J H Willis, Katheryn Grand, John M Graham, Richard A Lewis, Francisca Millan, Özgür Duman, Nihal Dündar, Gökhan Uyanik, Ludger Schöls, Peter Nürnberg, Gudrun Nürnberg, Andrea Catala Bordes, Pavel Seeman, Martin Kuchar, Hossein Darvish, Adriana Rebelo, Filipa Bouçanova, Jean-Jacques Medard, Roman Chrast, Michaela Auer-Grumbach, Fowzan S Alkuraya, Hanan Shamseldin, Saeed Al Tala, Jamileh Rezazadeh Varaghchi, Maryam Najafi, Selina Deschner, Dieter Gläser, Wolfgang Hüttel, Michael C Kruer, Erik-Jan Kamsteeg, Yoshihisa Takiyama, Stephan Züchner, Jonathan Baets, Matthis Synofzik, Rebecca Schüle, Rita Horvath, Henry Houlden, Luca Bartesaghi, Hwei-Jen Lee, Konstantinos Ampatzis, Tyler Mark Pierson, Jan Senderek, and Brain, 2021
Morquio B disease: From pathophysiology towards diagnosis Anna Caciotti, Lucrezia Cellai, Rodolfo Tonin, Davide Mei, Elena Procopio, Maja Di Rocco, Antonio Andaloro, Daniela Antuzzi, Angelica Rampazzo, Miriam Rigoldi, Giulia Forni, Giancarlo la Marca, Renzo Guerrini, Amelia Morrone Molecular Genetics and Metabolism, 2021
Targeted re-sequencing in pediatric and perinatal stroke Alice Grossi, Mariasavina Severino, Marta Rusmini, Domenico Tortora, Luca A. Ramenghi, Armando Cama, Andrea Rossi, Maja Di Rocco, Isabella Ceccherini, Marta Bertamino, Amico G, Banov L, Capra V, Caorsi R, Caroli F, Gandolfo C, Giacomini T, Molinari AC, Moretti P, Moscatelli A, Nobili L, Palmieri A, Pavanello M, Prato G, Rimini A, Ronchetti A, Signa S, Uccella S European Journal of Medical Genetics, 2020
Schimke immuno-osseous dysplasia, two new cases with peculiar EEG pattern Giulia Prato, Elisa De Grandis, Maria Margherita Mancardi, Ramona Cordani, Thea Giacomini, Livia Pisciotta, Sara Uccella, Mariasavina Severino, Domenico Tortora, Marco Pavanello, Marta Bertamino, Enrico Verrina, Gianluca Caridi, Maja Di Rocco, Lino Nobili Brain and Development, 2020
Molecular genetics of niemann–pick type c disease in italy: An update on 105 patients and description of 18 NPC1 novel variants Andrea Dardis, Stefania Zampieri, Cinzia Gellera, Rosalba Carrozzo, Silvia Cattarossi, Paolo Peruzzo, Rosalia Dariol, Annalisa Sechi, Federica Deodato, Claudio Caccia, Daniela Verrigni, Serena Gasperini, Agata Fiumara, Simona Fecarotta, Miryam Carecchio, Massimiliano Filosto, Lucia Santoro, Barbara Borroni, Andrea Bordugo, Francesco Brancati, Cinzia V. Russo, Maja Di Rocco, Antonio Toscano, Maurizio Scarpa, Bruno Bembi Journal of Clinical Medicine, 2020
Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP) Edward C. Hsiao, Maja Di Rocco, Amanda Cali, Michael Zasloff, Mona Al Mukaddam, Robert J. Pignolo, Zvi Grunwald, Coen Netelenbos, Richard Keen, Genevieve Baujat, Matthew A. Brown, Tae‐Joon Cho, Carmen De Cunto, Patricia Delai, Nobuhiko Haga, Rolf Morhart, Christiaan Scott, Keqin Zhang, Robert J. Diecidue, Clive S. Friedman, Fredrick S. Kaplan, Elisabeth M.W. Eekhoff British Journal of Clinical Pharmacology, 2019
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative Atul Mehta, David J. Kuter, Sam S. Salek, Nadia Belmatoug, Bruno Bembi, Jeremy Bright, Stephan vom Dahl, Federica Deodato, Maja Di Rocco, Ozlem Göker‐Alpan, Derralynn A. Hughes, Elena A. Lukina, Maciej Machaczka, Eugen Mengel, Aabha Nagral, Kimitoshi Nakamura, Aya Narita, Beatriz Oliveri, Gregory Pastores, Jordi Pérez‐López, Uma Ramaswami, Ida V. Schwartz, Jeff Szer, Neal J. Weinreb, Ari Zimran Internal Medicine Journal, 2019
Allogeneic hematopoietic cell transplantation in Farber disease Karoline Ehlert, Thierry Levade, Maja Di Rocco, Edoardo Lanino, Michael H. Albert, Monika Führer, Andrea Jarisch, Tayfun Güngör, Francis Ayuk, Josef Vormoor Journal of Inherited Metabolic Disease, 2019
UAV-based hyperspectral imaging for weed discrimination in maize R. Casa, S. Pascucci, S. Pignatti, A. Palombo, U. Nanni, A. Harfouche, L. Laura, M. Di Rocco, P. Fantozzi Precision Agriculture 2019 Papers Presented at the 12th European Conference on Precision Agriculture Ecpa 2019, 2019
ABCC6 mutations and early onset stroke: Two cases of a typical Pseudoxanthoma Elasticum Marta Bertamino, Mariasavina Severino, Alice Grossi, Marta Rusmini, Domenico Tortora, Carlo Gandolfo, Silvia Pederzoli, Clara Malattia, Paolo Picco, Pasquale Striano, Isabella Ceccherini, Maja Di Rocco, Alessia Aiello, Laura Banov, Valeria Capra, Thea Giacomini, Paola Lanteri, Francesca Minoia, Angelo Claudio Molinari, Paolo Moretti, Andrea Moscatelli, Maria Stella Vari, Antonella Palmieri, Marco Pavanello, Giulia Prato, Luca Antonio Ramenghi, Alessandro Rimini, Andrea Rossi, Sara Uccella European Journal of Paediatric Neurology, 2018
FAM46A mutations are responsible for autosomal recessive osteogenesis imperfecta Mathilde Doyard, Séverine Bacrot, Céline Huber, Maja Di Rocco, Alice Goldenberg, Mona S Aglan, Perrine Brunelle, Samia Temtamy, Caroline Michot, Ghada A Otaify, Coralie Haudry, Mireille Castanet, Julien Leroux, Jean-Paul Bonnefont, Arnold Munnich, Geneviève Baujat, Pablo Lapunzina, Sophie Monnot, Victor L Ruiz-Perez, Valérie Cormier-Daire Journal of Medical Genetics, 2018
The FOP Connection Registry: Design of an international patient-sponsored registry for Fibrodysplasia Ossificans Progressiva Neal Mantick, Eric Bachman, Genevieve Baujat, Matt Brown, Oliver Collins, Carmen De Cunto, Patricia Delai, Marelise Eekhoff, Roger zum Felde, Donna Roy Grogan, Nobuhiko Haga, Edward Hsiao, Sharon Kantanie, Frederick Kaplan, Richard Keen, Jelena Milosevic, Rolf Morhart, Robert Pignolo, Xiaobing Qian, Maja di Rocco, Christiaan Scott, Adam Sherman, Marin Wallace, Nicky Williams, Keqin Zhang, Betsy Bogard Bone, 2018
Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy Rossella Parini, Paola De Lorenzo, Andrea Dardis, Alberto Burlina, Alessandra Cassio, Paolo Cavarzere, Daniela Concolino, Roberto Della Casa, Federica Deodato, Maria Alice Donati, Agata Fiumara, Serena Gasperini, Francesca Menni, Veronica Pagliardini, Michele Sacchini, Marco Spada, Roberta Taurisano, Maria Grazia Valsecchi, Maja Di Rocco, Bruno Bembi Orphanet Journal of Rare Diseases, 2018
Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease M. Biegstraaten, T.M. Cox, N. Belmatoug, M.G. Berger, T. Collin-Histed, S. Vom Dahl, M. Di Rocco, C. Fraga, F. Giona, P. Giraldo, M. Hasanhodzic, D.A. Hughes, P.O. Iversen, A.I. Kiewiet, E. Lukina, M. Machaczka, T. Marinakis, E. Mengel, G.M. Pastores, U. Plöckinger, H. Rosenbaum, C. Serratrice, A. Symeonidis, J. Szer, J. Timmerman, A. Tylki-Szymańska, M. Weisz Hubshman, D.I. Zafeiriou, A. Zimran, C.E.M. Hollak Blood Cells Molecules and Diseases, 2018
International physician survey on management of FOP: A modified Delphi study Maja Di Rocco, Genevieve Baujat, Marta Bertamino, Matthew Brown, Carmen L. De Cunto, Patricia L. R. Delai, Elisabeth M. W. Eekhoff, Nobuhiko Haga, Edward Hsiao, Richard Keen, Rolf Morhart, Robert J. Pignolo, Frederick S. Kaplan Orphanet Journal of Rare Diseases, 2017
Muscle MRI of classic infantile pompe patients: Fatty substitution and edema-like changes Anna Pichiecchio, Marta Rossi, Claudia Cinnante, Giovanna Stefania Colafati, Roberto De Icco, Rossella Parini, Francesca Menni, Francesca Furlan, Alberto Burlina, Michele Sacchini, Maria Alice Donati, Simona Fecarotta, Roberto Della Casa, Federica Deodato, Roberta Taurisano, Maja Di Rocco Muscle and Nerve, 2017
EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay Stefano Volpi, Yasuhiro Yamazaki, Patrick M. Brauer, Ellen van Rooijen, Atsuko Hayashida, Anne Slavotinek, Hye Sun Kuehn, Maja Di Rocco, Carlo Rivolta, Ileana Bortolomai, Likun Du, Kerstin Felgentreff, Lisa Ott de Bruin, Kazutaka Hayashida, George Freedman, Genni Enza Marcovecchio, Kelly Capuder, Prisni Rath, Nicole Luche, Elliott J. Hagedorn, Antonella Buoncompagni, Beryl Royer-Bertrand, Silvia Giliani, Pietro Luigi Poliani, Luisa Imberti, Kerry Dobbs, Fabienne E. Poulain, Alberto Martini, John Manis, Robert J. Linhardt, Marita Bosticardo, Sergio Damian Rosenzweig, Hane Lee, Jennifer M. Puck, Juan Carlos Zúñiga-Pflücker, Leonard Zon, Pyong Woo Park, Andrea Superti-Furga, Luigi D. Notarangelo Journal of Experimental Medicine, 2017
Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy Shaalee Dworski, Ping Lu, Aneal Khan, Bruno Maranda, John J. Mitchell, Rossella Parini, Maja Di Rocco, Boris Hugle, Makoto Yoshimitsu, Bo Magnusson, Balahan Makay, Nur Arslan, Norberto Guelbert, Karoline Ehlert, Andrea Jarisch, Janet Gardner-Medwin, Rawane Dagher, Maria Teresa Terreri, Charles Marques Lorenco, Lilianna Barillas-Arias, Pranoot Tanpaiboon, Alexander Solyom, James S. Norris, Xingxuan He, Edward H. Schuchman, Thierry Levade, Jeffrey A. Medin Biochimica Et Biophysica Acta Molecular Basis of Disease, 2017
Open issues in Mucopolysaccharidosis type I-Hurler Rossella Parini, Federica Deodato, Maja Di Rocco, Edoardo Lanino, Franco Locatelli, Chiara Messina, Attilio Rovelli, Maurizio Scarpa Orphanet Journal of Rare Diseases, 2017
Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants Simon A. Jones, Vassili Valayannopoulos, Eugene Schneider, Stephen Eckert, Maryam Banikazemi, Martin Bialer, Stephen Cederbaum, Alicia Chan, Anil Dhawan, Maja Di Rocco, Jennifer Domm, Gregory M. Enns, David Finegold, J. Jay Gargus, Ornella Guardamagna, Christian Hendriksz, Iman G. Mahmoud, Julian Raiman, Laila A. Selim, Chester B. Whitley, Osama Zaki, Anthony G. Quinn Genetics in Medicine, 2016
Clinical Features of Lysosomal Acid Lipase Deficiency Barbara K. Burton, Patrick B. Deegan, Gregory M. Enns, Ornella Guardamagna, Simon Horslen, Gerard K. Hovingh, Steve J. Lobritto, Vera Malinova, Valerie A. McLin, Julian Raiman, Maja Di Rocco, Saikat Santra, Reena Sharma, Jolanta Sykut‐Cegielska, Chester B. Whitley, Stephen Eckert, Vassili Valayannopoulos, Anthony G. Quinn Journal of Pediatric Gastroenterology and Nutrition, 2015
Clinical Utility Gene Card for: Fibrodysplasia ossificans progressiva Nathalie Bravenboer, Dimitra Micha, James T Triffit, Alex N Bullock, Roberto Ravazollo, Renata Bocciardi, Maja di Rocco, J Coen Netelenbos, Peter Ten Dijke, Gonzalo Sánchez-Duffhues, Fred S Kaplan, Eileen M Shore, Robert J Pignolo, Petra Seemann, Francesc Ventura, Genevieve Beaujat, Elizabeth M W Eekhoff, Gerard Pals European Journal of Human Genetics, 2015
A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency Barbara K. Burton, Manisha Balwani, François Feillet, Ivo Barić, T. Andrew Burrow, Carmen Camarena Grande, Mahmut Coker, Alejandra Consuelo-Sánchez, Patrick Deegan, Maja Di Rocco, Gregory M. Enns, Richard Erbe, Fatih Ezgu, Can Ficicioglu, Katryn N. Furuya, John Kane, Christina Laukaitis, Eugen Mengel, Edward G. Neilan, Scott Nightingale, Heidi Peters, Maurizio Scarpa, K. Otfried Schwab, Vratislav Smolka, Vassili Valayannopoulos, Marnie Wood, Zachary Goodman, Yijun Yang, Stephen Eckert, Sandra Rojas-Caro, Anthony G. Quinn New England Journal of Medicine, 2015
Lack of prolidase causes a bone phenotype both in human and in mouse Roberta Besio, Silvia Maruelli, Roberta Gioia, Isabella Villa, Peter Grabowski, Orla Gallagher, Nicholas J. Bishop, Sarah Foster, Ersilia De Lorenzi, Raffaella Colombo, Josè Luis Dapena Diaz, Haether Moore-Barton, Charu Deshpande, Halil Ibrahim Aydin, Aysegul Tokatli, Bartlomiej Kwiek, Cigdem Seher Kasapkara, Esra Ozsoy Adisen, Mehmet Ali Gurer, Maja Di Rocco, James M. Phang, Teresa M. Gunn, Ruggero Tenni, Antonio Rossi, Antonella Forlino Bone, 2015
Optimizing the molecular diagnosis of GALNS: Novel methods to define and characterize morquio-A syndrome-associated mutations Anna Caciotti, Rodolfo Tonin, Miriam Rigoldi, Lorenzo Ferri, Serena Catarzi, Catia Cavicchi, Elena Procopio, Maria Alice Donati, Anna Ficcadenti, Agata Fiumara, Rita Barone, Livia Garavelli, Maja Di Rocco, Mirella Filocamo, Daniela Antuzzi, Maurizio Scarpa, Sean D. Mooney, Biao Li, Anastasia Skouma, Sebastiano Bianca, Daniela Concolino, Rosario Casalone, Elena Monti, Marilena Pantaleo, Sabrina Giglio, Renzo Guerrini, Rossella Parini, Amelia Morrone Human Mutation, 2015
Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C Simona Fecarotta, Alfonso Romano, Roberto Della Casa, Ennio Del Giudice, Diana Bruschini, Giuseppina Mansi, Bruno Bembi, Andrea Dardis, Agata Fiumara, Maja Di Rocco, Graziella Uziel, Anna Ardissone, Dario Roccatello, Mirella Alpa, Enrico Bertini, Adele D’Amico, Carlo Dionisi-Vici, Federica Deodato, Stefania Caviglia, Antonio Federico, Silvia Palmeri, Orazio Gabrielli, Lucia Santoro, Alessandro Filla, Cinzia Russo, Giancarlo Parenti, Generoso Andria Orphanet Journal of Rare Diseases, 2015
Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1 Yanick J. Crow, Diana S. Chase, Johanna Lowenstein Schmidt, Marcin Szynkiewicz, Gabriella M.A. Forte, Hannah L. Gornall, Anthony Oojageer, Beverley Anderson, Amy Pizzino, Guy Helman, Mohamed S. Abdel‐Hamid, Ghada M. Abdel‐Salam, Sam Ackroyd, Alec Aeby, Guillermo Agosta, Catherine Albin, Stavit Allon‐Shalev, Montse Arellano, Giada Ariaudo, Vijay Aswani, Riyana Babul‐Hirji, Eileen M. Baildam, Nadia Bahi‐Buisson, Kathryn M. Bailey, Christine Barnerias, Magalie Barth, Roberta Battini, Michael W. Beresford, Geneviève Bernard, Marika Bianchi, Thierry Billette de Villemeur, Edward M. Blair, Miriam Bloom, Alberto B. Burlina, Maria Luisa Carpanelli, Daniel R. Carvalho, Manuel Castro‐Gago, Anna Cavallini, Cristina Cereda, Kate E. Chandler, David A. Chitayat, Abigail E. Collins, Concepcion Sierra Corcoles, Nuno J.V. Cordeiro, Giovanni Crichiutti, Lyvia Dabydeen, Russell C. Dale, Stefano D′Arrigo, Christian G.E.L. De Goede, Corinne De Laet, Liesbeth M.H. De Waele, Ines Denzler, Isabelle Desguerre, Koenraad Devriendt, Maja Di Rocco, Michael C. Fahey, Elisa Fazzi, Colin D. Ferrie, António Figueiredo, Blanca Gener, Cyril Goizet, Nirmala R. Gowrinathan, Kalpana Gowrishankar, Donncha Hanrahan, Bertrand Isidor, Bülent Kara, Nasaim Khan, Mary D. King, Edwin P. Kirk, Ram Kumar, Lieven Lagae, Pierre Landrieu, Heinz Lauffer, Vincent Laugel, Roberta La Piana, Ming J. Lim, Jean‐Pierre S.‐M. Lin, Tarja Linnankivi, Mark T. Mackay, Daphna R. Marom, Charles Marques Lourenço, Shane A. McKee, Isabella Moroni, Jenny E.V. Morton, Marie‐Laure Moutard, Kevin Murray, Rima Nabbout, Sheela Nampoothiri, Noemi Nunez‐Enamorado, Patrick J. Oades, Ivana Olivieri, John R. Ostergaard, Belén Pérez‐Dueñas, Julie S. Prendiville, Venkateswaran Ramesh, Magnhild Rasmussen, Luc Régal, Federica Ricci, Marlène Rio, Diana Rodriguez, Agathe Roubertie, Elisabetta Salvatici, Karin A. Segers, Gyanranjan P. Sinha, Doriette Soler, Ronen Spiegel, Tommy I. Stödberg, Rachel Straussberg, Kathryn J. Swoboda, Mohnish Suri, Uta Tacke, Tiong Y. Tan, Johann te Water Naude, Keng Wee Teik, Maya Mary Thomas, Marianne Till, Davide Tonduti, Enza Maria Valente, Rudy Noel Van Coster, Marjo S. van der Knaap, Grace Vassallo, Raymon Vijzelaar, Julie Vogt, Geoffrey B. Wallace, Evangeline Wassmer, Hannah J. Webb, William P. Whitehouse, Robyn N. Whitney, Maha S. Zaki, Sameer M. Zuberi, John H. Livingston, Flore Rozenberg, Pierre Lebon, Adeline Vanderver, Simona Orcesi, Gillian I. Rice American Journal of Medical Genetics Part A, 2015
Myhre and LAPS syndromes: Clinical and molecular review of 32 patients Caroline Michot, Carine Le Goff, Clémentine Mahaut, Alexandra Afenjar, Alice S Brooks, Philippe M Campeau, Anne Destree, Maja Di Rocco, Dian Donnai, Raoul Hennekam, Delphine Heron, Sébastien Jacquemont, Peter Kannu, Angela E Lin, Sylvie Manouvrier-Hanu, Sahar Mansour, Sandrine Marlin, Ruth McGowan, Helen Murphy, Annick Raas-Rothschild, Marlène Rio, Marleen Simon, Irene Stolte-Dijkstra, James R Stone, Yves Sznajer, John Tolmie, Renaud Touraine, Jenneke van den Ende, Nathalie Van der Aa, Ton van Essen, Alain Verloes, Arnold Munnich, Valérie Cormier-Daire European Journal of Human Genetics, 2014
Mutations in SH3PXD2B cause Borrone dermato-cardio-skeletal syndrome Gabrielle R Wilson, Jasmine Sunley, Katherine R Smith, Kate Pope, Catherine J Bromhead, Elizabeth Fitzpatrick, Maja Di Rocco, Maurice van Steensel, David J Coman, Richard J Leventer, Martin B Delatycki, David J Amor, Melanie Bahlo, Paul J Lockhart European Journal of Human Genetics, 2014
EXOSC3 mutations in isolated cerebellar hypoplasia and spinal anterior horn involvement Roberta Biancheri, Denise Cassandrini, Francesca Pinto, Rosanna Trovato, Maja Di Rocco, Marisol Mirabelli-Badenier, Marina Pedemonte, Chiara Panicucci, Holger Trucks, Thomas Sander, Federico Zara, Andrea Rossi, Pasquale Striano, Carlo Minetti, Filippo Maria Santorelli Journal of Neurology, 2013
In-frame mutations in exon 1 of SKI cause dominant shprintzen-goldberg syndrome Virginie Carmignac, Julien Thevenon, Lesley Adès, Bert Callewaert, Sophie Julia, Christel Thauvin-Robinet, Lucie Gueneau, Jean-Benoit Courcet, Estelle Lopez, Katherine Holman, Marjolijn Renard, Henri Plauchu, Ghislaine Plessis, Julie De Backer, Anne Child, Gavin Arno, Laurence Duplomb, Patrick Callier, Bernard Aral, Pierre Vabres, Nadège Gigot, Eloisa Arbustini, Maurizia Grasso, Peter N. Robinson, Cyril Goizet, Clarisse Baumann, Maja Di Rocco, Jaime Sanchez Del Pozo, Frédéric Huet, Guillaume Jondeau, Gwenaëlle Collod-Beroud, Christophe Beroud, Jeanne Amiel, Valérie Cormier-Daire, Jean-Baptiste Rivière, Catherine Boileau, Anne De Paepe, Laurence Faivre American Journal of Human Genetics, 2012
Minimal disease activity in Gaucher disease: Criteria for definition Maja Di Rocco, Generoso Andria, Bruno Bembi, Francesca Carubbi, Fiorina Giona, Gaetano Giuffrida, Silvia Linari, Michelina Sibilio, Vincenzo Spina, Maria Domenica Cappellini Molecular Genetics and Metabolism, 2012
The diagnostic challenge of progressive pseudorheumatoid dysplasia (PPRD): A review of clinical features, radiographic features, and WISP3 mutations in 63 affected individuals Nuria Garcia Segarra, Laureane Mittaz, Ana Belinda Campos‐Xavier, Cynthia F. Bartels, Beyhan Tuysuz, Yasemin Alanay, Rolando Cimaz, Valerie Cormier‐Daire, Maja Di Rocco, Hans‐Christoph Duba, Nursel H. Elcioglu, Francesca Forzano, Toni Hospach, Esra Kilic, Jasmin B. Kuemmerle‐Deschner, Geert Mortier, Sonja Mrusek, Sheela Nampoothiri, Ewa Obersztyn, Richard M. Pauli, Angelo Selicorni, Romano Tenconi, Sheila Unger, G. Eda Utine, Michael Wright, Bernhard Zabel, Matthew L. Warman, Andrea Superti‐Furga, Luisa Bonafé American Journal of Medical Genetics Part C Seminars in Medical Genetics, 2012
Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome Carine Le Goff, Clémentine Mahaut, Avinash Abhyankar, Wilfried Le Goff, Valérie Serre, Alexandra Afenjar, Anne Destrée, Maja di Rocco, Delphine Héron, Sébastien Jacquemont, Sandrine Marlin, Marleen Simon, John Tolmie, Alain Verloes, Jean-Laurent Casanova, Arnold Munnich, Valérie Cormier-Daire Nature Genetics, 2012
Hypomyelination and congenital cataract: Broadening the clinical phenotype Roberta Biancheri, Federico Zara, Andrea Rossi, Mikael Mathot, Marie Cecile Nassogne, Cengiz Yalcinkaya, Ozdem Erturk, Behyan Tuysuz, Maja Di Rocco, Elisabetta Gazzerro, Marianna Bugiani, Resie van Spaendonk, Erik A. Sistermans, Carlo Minetti, Marjo S. van der Knaap, Nicole I. Wolf Archives of Neurology, 2011
GM1 gangliosidosis and Morquio B disease: An update on genetic alterations and clinical findings Anna Caciotti, Scott C. Garman, Yadilette Rivera-Colón, Elena Procopio, Serena Catarzi, Lorenzo Ferri, Carmen Guido, Paola Martelli, Rossella Parini, Daniela Antuzzi, Roberta Battini, Michela Sibilio, Alessandro Simonati, Elena Fontana, Alessandro Salviati, Gulcin Akinci, Cristina Cereda, Carlo Dionisi-Vici, Francesca Deodato, Adele d'Amico, Alessandra d'Azzo, Enrico Bertini, Mirella Filocamo, Maurizio Scarpa, Maja di Rocco, Cynthia J. Tifft, Federica Ciani, Serena Gasperini, Elisabetta Pasquini, Renzo Guerrini, Maria Alice Donati, Amelia Morrone Biochimica Et Biophysica Acta Molecular Basis of Disease, 2011
Brain and spine MRI features of Hunter disease: Frequency, natural evolution and response to therapy Renzo Manara, Elena Priante, Marco Grimaldi, Lucia Santoro, Luca Astarita, Rita Barone, Daniela Concolino, Maja Di Rocco, Maria Alice Donati, Simona Fecarotta, Anna Ficcadenti, Agata Fiumara, Francesca Furlan, Irene Giovannini, Franco Lilliu, Rodica Mardari, Gabriele Polonara, Elena Procopio, Angelica Rampazzo, Andrea Rossi, Graziolina Sanna, Rossella Parini, Maurizio Scarpa Journal of Inherited Metabolic Disease, 2011
Pontocerebellar hypoplasia: Clinical, pathologic, and genetic studies D. Cassandrini, R. Biancheri, A. Tessa, M. Di Rocco, M. Di Capua, C. Bruno, P.S. Denora, S. Sartori, A. Rossi, P. Nozza, F. Emma, P. Mezzano, M.R. Politi, A.M. Laverda, F. Zara, L. Pavone, A. Simonati, V. Leuzzi, F.M. Santorelli, E. Bertini Neurology, 2010
Angelman syndrome: EEG's role Bollettino Lega Italiana Contro L Epilessia, 2010
Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization Andrew R Cullinane, Anna Straatman-Iwanowska, Andreas Zaucker, Yoshiyuki Wakabayashi, Christopher K Bruce, Guanmei Luo, Fatimah Rahman, Figen Gürakan, Eda Utine, Tanju B Özkan, Jonas Denecke, Jurica Vukovic, Maja Di Rocco, Hanna Mandel, Hakan Cangul, Randolph P Matthews, Steve G Thomas, Joshua Z Rappoport, Irwin M Arias, Hartwig Wolburg, A S Knisely, Deirdre A Kelly, Ferenc Müller, Eamonn R Maher, Paul Gissen Nature Genetics, 2010
Force Majeure: Therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease Carla E.M. Hollak, Stephan vom Dahl, Johannes M.F.G. Aerts, Nadia Belmatoug, Bruno Bembi, Yossi Cohen, Tanya Collin-Histed, Patrick Deegan, Laura van Dussen, Pilar Giraldo, Eugen Mengel, Helen Michelakakis, Jeremy Manuel, Martin Hrebicek, Rosella Parini, Jörg Reinke, Maja di Rocco, Miguel Pocovi, Maria Clara Sa Miranda, Anna Tylki-Szymanska, Ari Zimran, Timothy M. Cox Blood Cells Molecules and Diseases, 2010
Infection-Triggered Familial or Recurrent Cases of Acute Necrotizing Encephalopathy Caused by Mutations in a Component of the Nuclear Pore, RANBP2 Derek E. Neilson, Mark D. Adams, Caitlin M.D. Orr, Deborah K. Schelling, Robert M. Eiben, Douglas S. Kerr, Jane Anderson, Alexander G. Bassuk, Ann M. Bye, Anne-Marie Childs, Antonia Clarke, Yanick J. Crow, Maja Di Rocco, Christian Dohna-Schwake, Gregor Dueckers, Alfonso E. Fasano, Artemis D. Gika, Dimitris Gionnis, Mark P. Gorman, Padraic J. Grattan-Smith, Annette Hackenberg, Alice Kuster, Markus G. Lentschig, Eduardo Lopez-Laso, Elysa J. Marco, Sotiria Mastroyianni, Julie Perrier, Thomas Schmitt-Mechelke, Serenella Servidei, Angeliki Skardoutsou, Peter Uldall, Marjo S. van der Knaap, Karrie C. Goglin, David L. Tefft, Cristin Aubin, Philip de Jager, David Hafler, Matthew L. Warman American Journal of Human Genetics, 2009
Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion Paola S. Denora, David Schlesinger, Carlo Casali, Fernando Kok, Alessandra Tessa, Amir Boukhris, Hamid Azzedine, Maria Teresa Dotti, Claudio Bruno, Jeremy Truchetto, Roberta Biancheri, Estelle Fedirko, Maja Di Rocco, Clarissa Bueno, Alessandro Malandrini, Roberta Battini, Elisabeth Sickl, Maria Fulvia de Leva, Odile Boespflug-Tanguy, Gabriella Silvestri, Alessandro Simonati, Edith Said, Andreas Ferbert, Chiara Criscuolo, Karl Heinimann, Anna Modoni, Peter Weber, Silvia Palmeri, Martina Plasilova, Flavia Pauri, Denise Cassandrini, Carla Battisti, Antonella Pini, Michela Tosetti, Erwin Hauser, Marcella Masciullo, Roberto Di Fabio, Francesca Piccolo, Elodie Denis, Giovanni Cioni, Roberto Massa, Elvio Della Giustina, Olga Calabrese, Marina A.B. Melone, Giuseppe De Michele, Antonio Federico, Enrico Bertini, Alexandra Durr, Knut Brockmann, Marjo S. van der Knaap, Mayana Zatz, Alessandro Filla, Alexis Brice, Giovanni Stevanin, Filippo M. Santorelli Human Mutation, 2009
Clinical and genetic characterization of Chanarin-Dorfman syndrome Claudio Bruno, Enrico Bertini, Maja Di Rocco, Denise Cassandrini, Giuseppe Ruffa, Teresa De Toni, Marco Seri, Marco Spada, Giovanni Li Volti, Adele D’Amico, Federica Trucco, Marcello Arca, Carlo Casali, Corrado Angelini, Salvatore DiMauro, Carlo Minetti Biochemical and Biophysical Research Communications, 2008
The Italian XLMR bank: A clinical and molecular database C. Pescucci, R. Caselli, F. Mari, C. Speciale, F. Ariani, M. Bruttini, K. Sampieri, M.A. Mencarelli, E. Scala, I. Longo, R. Artuso, A. Renieri, I. Meloni, the Members of the XLMR Italian Network Human Mutation, 2007
Clinical and molecular genetic features of ARC syndrome Paul Gissen, Louise Tee, Colin A. Johnson, Emmanuelle Genin, Almuth Caliebe, David Chitayat, Carol Clericuzio, Jonas Denecke, Maja Di Rocco, Björn Fischler, David FitzPatrick, Angeles García-Cazorla, Delphine Guyot, Sebastien Jacquemont, Sibylle Koletzko, Bruno Leheup, Hanna Mandel, Maria Teresa Vieira Sanseverino, Roderick H. J. Houwen, Patrick J. McKiernan, Deirdre A. Kelly, Eamonn R. Maher Human Genetics, 2006
Agenesis of the corpus callosum: Clinical and genetic study in 63 young patients Maria Francesca Bedeschi, Maria Clara Bonaglia, Rita Grasso, Alda Pellegri, Rosaria Rita Garghentino, Maria Amalia Battaglia, Anna Maria Panarisi, Maja Di Rocco, Umberto Balottin, Nereo Bresolin, Maria Teresa Bassi, Renato Borgatti Pediatric Neurology, 2006
Null Leukemia Inhibitory Factor Receptor (LIFR) Mutations in Stüve-Wiedemann/Schwartz-Jampel Type 2 Syndrome Nathalie Dagoneau, Deborah Scheffer, Céline Huber, Lihadh I. Al-Gazali, Maja Di Rocco, Anne Godard, Jelena Martinovic, Annick Raas-Rothschild, Sabine Sigaudy, Sheila Unger, Sophie Nicole, Bertrand Fontaine, Jean-Luc Taupin, Jean-François Moreau, Andrea Superti-Furga, Martine Le Merrer, Jacky Bonaventure, Arnold Munnich, Laurence Legeai-Mallet, Valérie Cormier-Daire American Journal of Human Genetics, 2004
Concerning "five additional Costello syndrome patients with rhabdomyosarcoma: Proposal for a tumor screening protocol" [3] American Journal of Medical Genetics, 2003
Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations [9] Elena Rossi, Flavia Piccini, Marcella Zollino, Giovanni Neri, Desirée Caselli, Romano Tenconi, Claudio Castellan, Romeo Carrozzo, Cesare Danesino, Orsetta Zuffardi, Angela Ragusa, Lucia Castiglia, Ornella Galesi, Donatella Greco, Corrado Romano, Mauro Pierluigi, Chiara Perfumo, Maia Di Rocco, Francesca Faravelli, Franca Dagna Bricarelli, MariaClara Bonaglia, MariaFrancesca Bedeschi, Renato Borgatti Journal of Medical Genetics, 2001
Genotype-phenotype correlations and clinical diagnostic criteria in Wolf-Hirschhorn syndrome Marcella Zollino, Cristina Di Stefano, Giuseppe Zampino, Pierpaolo Mastroiacovo, Tracy J. Wright, Giovanni Sorge, Angelo Selicorni, Romano Tenconi, Alessandro Zappal�, Agatino Battaglia, Maja Di Rocco, Giandomenico Palka, Rosanna Pallotta, Michael R. Altherr, Giovanni Neri American Journal of Medical Genetics, 2000
Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance Maria Pia Sperandeo, Maria Teresa Bassi, Mirko Riboni, Giancarlo Parenti, Anna Buoninconti, Marta Manzoni, Barbara Incerti, Maria Rosaria Larocca, Maja Di Rocco, Pietro Strisciuglio, Irma Dianzani, Rossella Parini, Miranda Candito, Fumio Endo, Andrea Ballabio, Generoso Andria, Gianfranco Sebastio, Giuseppe Borsani American Journal of Human Genetics, 2000
Ataxia, ocular telangiectasia, chromosome instability, and Langerhans cell histiocytosis in a patient with an unknown breakage syndrome Journal of Medical Genetics, 1999
Erratum: Complications of lysinuric protein intolerance must be treated with immunosuppressive drugs (Journal of Inherited Metabolic Disease (1998) 21, 6 (675-676)) Journal of Inherited Metabolic Disease, 1999
Complex spinal malformation in a 8-month-old girl Rivista Italiana Di Pediatria, 1998
Molecular epidemiology of glycogen storage disease type 1a in italian causistics: Application to non invasive diagnosis and prevention Rivista Italiana Di Pediatria, 1997
Case of the month: A child with stiff neck M. Di Rocco, L. Tasso, M. P. Fondelli, C. Marino, M. Romanengo, R. Giacchino, C. Borrone European Journal of Pediatrics, 1997
Report on a patient with congenital muscular distrophy, hydrocephalus, Dandy-Walker malformation and leukodystrophy Genetic Counseling, 1993
Sinus histocytosis with massive lymphadenopathy (Rosai-Dorfman's disease): Heterogeneity of the clinical picture and positive response to the chemotherapic treatment in a pediatric case Rivista Italiana Di Pediatria, 1993
Use of computer programs in the education and self-management of patients with insulin-dependent diabetes mellitus La Pediatria Medica E Chirurgica Medical and Surgical Pediatrics, 1991
Diagnostic and therapeutic approach to hepatic glycogenoses. Report of 36 patients Rivista Italiana Di Pediatria, 1990
Status of the deciduous dentition of 3-7-year old children in Bouches-du-Rhône Le Chirurgien Dentiste De France, 1987
Cytochrome c oxidase deficiency in leigh syndrome Salvatore DiMauro, Serenella Servidei, Massimo Zeviani, Maja DiRocco, Darryl C. DeVivo, Stefano DiDonato, Graziella Uziel, Kenneth Berry, George Hoganson, Stanley D. Johnsen, Peter C. Johnson Annals of Neurology, 1987
Atypical non-ketotic hyperglycinaemia C. Borrone, C. Bachmann, M. Di Rocco, K. Tada, K. Hayasaka, R. Gatti Journal of Inherited Metabolic Disease, 1986
Presentation of the data of the Italian registry for oculocutaneous tyrosinaemia A. Fois, P. Borgogni, M. Cioni, M. Molinelli, R. Frezzotti, A. M. Bardelli, G. Lasorella, L. Barberi, P. Durand, M. Di Rocco, C. Romano, R. Parini, C. Corbetta, M. Giovannini, E. Riva, N. Balato, R. Sartorio, F. Mollica, E. Zammarchi, M. L. Battini Journal of Inherited Metabolic Disease, 1986
Fucosidosis: Review of personal experience Pediatria Medica E Chirurgica, 1982
Clinical heterogeneity in fructose intolerance Pediatria Medica E Chirurgica, 1982
Gaucher's disease. Longitudinal-study in 17 patients in a 10-year period (1970-1980) Pediatria Medica E Chirurgica, 1981
Therapeutic problems of adreno-genital syndrome due to 21-hydroxylase deficiency with loss of salts. Appearance of signs of overdose at the normally used doses Minerva Pediatrica, 1981
RECENT SCHOLAR PUBLICATIONS
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a plain language summary of a post hoc analysis of the LUMINA-1 trial R Keen, KM Dahir, J McGinniss, RJ Sanchez, S Mellis, AN Economides, ... Future Rare Diseases 6 (1), 2635334 , 2026 2026
Mitochondrial energetic failure underlies FLVCR1-related sensory neuropathy F Bertino, DI Zanin Venturini, E Grasso, J Kopecka, C Salio, B Gnutti, ... Communications Biology , 2026 2026 Citations: 1
Hearing loss predictive model in fibrodysplasia ossificans progressiva from a national referral center: developing an hearing loss predictive model T Cacco, R Papa, L Carmisciano, C Bruzzo, L Semino, A Tonelli, ... JBMR plus 9 (4), ziaf029 , 2025 2025
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a post hoc analysis of the randomized, double-blind, placebo … R Keen, KM Dahir, J McGinniss, RJ Sanchez, S Mellis, AN Economides, ... Journal of Bone and Mineral Research 39 (10), 1486-1492 , 2024 2024 Citations: 10
3-3. OTHER SKELETAL ANOMALIES OF FOP RJ Pignolo, K Cheung, S Kile, MA Fitzpatrick, C De Cunto, ... THE FOP TREATMENT GUIDELINES 134, 15 , 2024 2024
5-12. DEVELOPMENTAL ARTHROPATHY AND DEGENERATIVE JOINT DISEASE IN FOP M Severino, M Bertamino, D Tortora, G Morana, S Uccella, R Bocciardi, ... THE FOP TREATMENT GUIDELINES 53, 85 , 2024 2024
Dysregulation of FLVCR1a-dependent mitochondrial calcium handling in neural progenitors causes congenital hydrocephalus F Bertino, D Mukherjee, M Bonora, C Bagowski, J Nardelli, L Metani, ... Cell Reports Medicine 5 (7) , 2024 2024 Citations: 11
The effects of garetosmab in people with fibrodysplasia ossificans progressiva (FOP): A plain language summary of the LUMINA-1 study MD Rocco, R J Pignolo, R Keen, D Srinivasan, S J Mellis, M Davis, ... Future Rare Diseases 4 (1), FRD63 , 2024 2024
Multicentric Carpo-Tarsal Osteolysis Syndrome (MCTO) and “Function Profile”: a rehabilitative approach AB Ronchetti, M Usai, V Savino, M Scaglione, CM Tacchino, M Bertamino, ... Orphanet Journal of Rare Diseases 18 (1), 392 , 2023 2023 Citations: 2
The Relationship of Flare-Ups and Heterotopic Ossification in Patients with Fibrodysplasia Ossificans Progressiva: LUMINA-1 Data R Keen, J McGinniss, E Forleo-Neto, S Mellis, K Dahir, M Di Rocco, ... JOURNAL OF BONE AND MINERAL RESEARCH 38, 71-71 , 2023 2023
Flare-Ups in Patients with Fibrodysplasia Ossificans Progressiva Reduced by Garetosmab Treatment: LUMINA-1 Data K Dahir, J McGinniss, E Forle-Neto, S Mellis, R Sanchez, M Di Rocco, ... JOURNAL OF BONE AND MINERAL RESEARCH 38, 70-70 , 2023 2023
OR29-06 Flare-Ups In Patients With Fibrodysplasia Ossificans Progressiva Reduced By Garetosmab Treatment: LUMINA-1 Data KM Dahir, J McGinniss, E Forleo-Neto, S Mellis, RJ Sanchez, M Di Rocco, ... Journal of the Endocrine Society 7 (Supplement_1), bvad114. 571 , 2023 2023
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial M Di Rocco, E Forleo-Neto, RJ Pignolo, R Keen, P Orcel, ... Nature Medicine 29 (10), 2615-2624 , 2023 2023 Citations: 62
Screening for lysosomal diseases in a selected pediatric population: The case of Gaucher disease and acid sphingomyelinase deficiency M Di Rocco, CD Vici, A Burlina, F Venturelli, A Fiumara, S Fecarotta, ... Orphanet Journal of Rare Diseases 18 (1), 197 , 2023 2023 Citations: 10
GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia A Pession, M Di Rocco, F Venturelli, B Tappino, W Morello, N Santoro, ... Orphanet Journal of Rare Diseases 18 (1), 151 , 2023 2023 Citations: 12
Acid sphingomyelinase deficiency (ASMD): Addressing knowledge gaps in unmet needs and patient journey in Italy—A Delphi consensus M Scarpa, A Barbato, A Bisconti, A Burlina, D Concolino, F Deodato, ... Internal and Emergency Medicine 18 (3), 831-842 , 2023 2023 Citations: 11
Garetosmab, an inhibitor of activin A, reduces heterotopic ossification and flare-ups in adults with fibrodysplasia ossificans progressiva: A randomized, double-blind, placebo … M Di Rocco, E Forleo-Neto, R Pignolo, R Keen, P Orcel, ... medRxiv, 2023.01. 11.23284254 , 2023 2023 Citations: 6
Long-term bone outcomes in Italian patients with Gaucher disease type 1 or type 3 treated with imiglucerase: a sub-study from the International Collaborative Gaucher Group … MD Cappellini, F Carubbi, M Di Rocco, F Giona, G Giuffrida Blood Cells, Molecules, and Diseases 98, 102705 , 2023 2023 Citations: 18
Gene therapy for fibrodysplasia ossificans progressiva: feasibility and obstacles EMW Eekhoff, RD De Ruiter, BJ Smilde, T Schoenmaker, TJ De Vries, ... Human gene therapy 33 (15-16), 782-788 , 2022 2022 Citations: 20
Search for biomarkers and prognostic indicators of liver degeneration in glycogen storage disease type Ia R Resaz, D Cangelosi, D Segalerba, M Morini, MC Bosco, S Paci, A Sechi, ... Journal of Hepatology 77, S515 , 2022 2022
MOST CITED SCHOLAR PUBLICATIONS
Characterization of human disease phenotypes associated with mutations in TREX1 , RNASEH2A , RNASEH2B , RNASEH2C , SAMHD1 , ADAR , and IFIH1 YJ Crow, DS Chase, J Lowenstein Schmidt, M Szynkiewicz, GMA Forte, ... American journal of medical genetics Part A 167 (2), 296-312 , 2015 2015 Citations: 721
Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2 DE Neilson, MD Adams, CMD Orr, DK Schelling, RM Eiben, DS Kerr, ... The American Journal of Human Genetics 84 (1), 44-51 , 2009 2009 Citations: 419
Mutations in VPS33B , encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis–renal dysfunction–cholestasis (ARC) syndrome P Gissen, CA Johnson, NV Morgan, JM Stapelbroek, T Forshew, ... Nature genetics 36 (4), 400-404 , 2004 2004 Citations: 388
A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency BK Burton, M Balwani, F Feillet, I Barić, TA Burrow, C Camarena Grande, ... New England Journal of Medicine 373 (11), 1010-1020 , 2015 2015 Citations: 329
Guidelines for management of glycogen storage disease type I–European Study on Glycogen Storage Disease Type I (ESGSD I) J Rake, G Visser, P Labrune, JV Leonard, K Ullrich, PG Smit European Journal of Pediatrics 161 (Suppl 1), S112-S119 , 2002 2002 Citations: 295
Agenesis of the corpus callosum: clinical and genetic study in 63 young patients MF Bedeschi, MC Bonaglia, R Grasso, A Pellegri, RR Garghentino, ... Pediatric neurology 34 (3), 186-193 , 2006 2006 Citations: 239
Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization AR Cullinane, A Straatman-Iwanowska, A Zaucker, Y Wakabayashi, ... Nature genetics 42 (4), 303-312 , 2010 2010 Citations: 214
Genotype–phenotype correlations and clinical diagnostic criteria in Wolf‐Hirschhorn syndrome M Zollino, C Di Stefano, G Zampino, P Mastroiacovo, TJ Wright, G Sorge, ... American journal of medical genetics 94 (3), 254-261 , 2000 2000 Citations: 210
GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings A Caciotti, SC Garman, Y Rivera-Colón, E Procopio, S Catarzi, L Ferri, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (7), 782-790 , 2011 2011 Citations: 201
Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome C Le Goff, C Mahaut, A Abhyankar, W Le Goff, V Serre, A Afenjar, ... Nature genetics 44 (1), 85-88 , 2012 2012 Citations: 192
Null leukemia inhibitory factor receptor (LIFR) mutations in Stüve-Wiedemann/Schwartz-Jampel type 2 syndrome N Dagoneau, D Scheffer, C Huber, LI Al-Gazali, M Di Rocco, A Godard, ... The American Journal of Human Genetics 74 (2), 298-305 , 2004 2004 Citations: 192
Revised recommendations for the management of Gaucher disease in children P Kaplan, H Baris, L De Meirleir, M Di Rocco, A El-Beshlawy, M Huemer, ... European journal of pediatrics 172 (4), 447-458 , 2013 2013 Citations: 182
Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease M Biegstraaten, TM Cox, N Belmatoug, MG Berger, T Collin-Histed, ... Blood Cells, Molecules, and Diseases 68, 203-208 , 2018 2018 Citations: 164
Clinical and molecular genetic features of ARC syndrome P Gissen, L Tee, CA Johnson, E Genin, A Caliebe, D Chitayat, ... Human genetics 120 (3), 396-409 , 2006 2006 Citations: 162
Clinical features of lysosomal acid lipase deficiency BK Burton, PB Deegan, GM Enns, O Guardamagna, S Horslen, ... Journal of pediatric gastroenterology and nutrition 61 (6), 619-625 , 2015 2015 Citations: 159
Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations E Rossi, F Piccini, M Zollino, G Neri, D Caselli, R Tenconi, C Castellan, ... Journal of medical genetics 38 (6), 417-420 , 2001 2001 Citations: 158
Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease B Tappino, R Biancheri, M Mort, S Regis, F Corsolini, A Rossi, ... Human mutation 31 (12), E1894-E1914 , 2010 2010 Citations: 157
Mutations in OSTM1 (Grey Lethal) Define a Particularly Severe Form of Autosomal Recessive Osteopetrosis With Neural Involvement A Pangrazio, PL Poliani, A Megarbane, G Lefranc, E Lanino, M Di Rocco, ... Journal of Bone and Mineral Research 21 (7), 1098-1105 , 2006 2006 Citations: 150
Natural history of vanishing white matter EMC Hamilton, HDW van der Lei, G Vermeulen, JAM Gerver, ... Annals of neurology 84 (2), 274-288 , 2018 2018 Citations: 145
In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome V Carmignac, J Thevenon, L Adès, B Callewaert, S Julia, ... The American Journal of Human Genetics 91 (5), 950-957 , 2012 2012 Citations: 144